Ulrike is W3 Professor of Immuno-Oncology at the University of Leipzig, Director of the Institute for Clinical Immunology at Leipzig University Hospital, and Managing Director of the Fraunhofer Institute for Cell Therapy & Immunology (IZI). She studied biology and medicine at Goethe University Frankfurt, earning a PhD in pharmacology and a Habilitation in experimental medicine, followed by a postdoctoral fellowship at MD Anderson Cancer Center. Since 2017, she has led Fraunhofer IZI’s cell and gene therapy division, advancing CAR T and CAR NK cell therapies through GMP-compliant processes, immunomonitoring, and EU collaborations like SaxoCell. Author of 190+ papers, she drives next-generation immunotherapies.

‍